(Q36552392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christian Zuppinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Theo Wallimann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Uwe Schlattner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

Malgorzata Tokarska-Schlattner

28 December 2019

1

object named as

Malgorzata Tokarska-Schlattner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

389-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16879835%20AND%20SRC:MED&resulttype=core&format=json

Strategies for prevention of anthracycline cardiotoxicity

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin-induced apoptosis: implications in cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Beginnings of a signal-transduction pathway for bioenergetic control of cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondria as a pharmacological target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Failing energetics in failing hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Is the failing heart energy starved? On using chemical energy to support cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Energy metabolism in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin-induced cardiac mitochondrionopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Role of iron in anthracycline cardiotoxicity: new tunes for an old song?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Molecular basis of anthracycline-induced cardiotoxicity and its prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiotoxicity of doxorubicin and other anthracycline derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiotoxicity of cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiomyopathy Caused by Antineoplastic Therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Anthracycline-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cytofluorescence detection of adriamycin-mitochondria interactions in isolated, perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Apoptotic versus autophagic cell death in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Myocytes die by multiple mechanisms in failing human hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Age-dependent declines in proteasome activity in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Concentrations of human cardiac phosphorus metabolites determined by SLOOP 31P NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31P-NMR and implications for adriamycin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin: Effect on mammalian cardiac cells in culture I. Cell population and energy metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

A protective effect of coenzyme Q10 on the adriamycin-induced cardiotoxicity in the isolated perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Structural and functional impairment of mitochondria in adriamycin-induced cardiomyopathy in mice: suppression of cytochrome c oxidase II gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effect of adriamycin on electron transport in rat heart, liver, and tumor mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Inhibition of mitochondrial oxidative phosphorylation by adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of Adriamycin on heart mitochondrial function in rested and exercised rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Anthracycline glycoside-membrane interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Inactivation of mitochondrial succinate dehydrogenase by adriamycin activated by horseradish peroxidase and hydrogen peroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial H(+) leak and ROS generation: an odd couple

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial creatine kinase in human health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The mitochondrial phosphate carrier reconstituted in liposomes is inhibited by doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin inhibits the phosphate-transport protein reconstituted in liposomes. A study on the mechanism of the inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiolipins and mitochondrial proton-selective leakage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial targets of drug toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin Cardiotoxicity: possible pathogenic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Immediate effects of anticancer drugs on mitochondrial oxygen consumption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrials complex I activity is reduced in latent adriamycin-induced cardiomyopathy of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

In vivo measurement of myocardial oxidative metabolism and blood flow does not show changes in cancer patients undergoing doxorubicin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Myocardial O2 consumption in porcine left ventricle is heterogeneously distributed in parallel to heterogeneous O2 delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Modulation of adriamycin-induced changes in serum free fatty acids, albumin and cardiac oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The mechanisms of fatty acid-induced proton permeability of the inner mitochondrial membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The creatine-creatine phosphate energy shuttle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiac system bioenergetics: metabolic basis of the Frank-Starling law.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Isoenzyme-specific interaction of muscle-type creatine kinase with the sarcomeric M-line is mediated by NH(2)-terminal lysine charge-clamps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

A spin-label electron spin resonance study of the binding of mitochondrial creatine kinase to cardiolipin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Crystal structure of brain-type creatine kinase at 1.41 Å resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Structure of mitochondrial creatine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Inactivation of creatine kinase by Adriamycin during interaction with horseradish peroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin-Fe(3+)-induced inactivation of rat heart mitochondrial creatine kinase: sensitivity to lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Thiol oxidation induced by oxidative action of adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Free radical-induced inactivation of creatine kinase: influence on the octameric and dimeric states of the mitochondrial enzyme (Mib-CK).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Octamer-dimer Transitions of Mitochondrial Creatine Kinase in Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Creatine and creatinine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

CK flux or direct ATP transfer: versatility of energy transfer pathways evidenced by NMR in the perfused heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Myocardial contractile efficiency increases in proportion to a fetal enzyme shift in chronically infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

A molecular approach to the concerted action of kinases involved in energy homoeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Intramuscular mechanisms regulating fatty acid oxidation during exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Role of exercise in rehabilitation of cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardiolipin and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The biosynthesis and functional role of cardiolipin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effect of Adriamycin on the boundary lipid structure of cytochrome c oxidase: pico-second time-resolved fluorescence depolarization studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondria as subcellular targets for clinically useful anthracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Role of oxidative stress in myocardial hypertrophy and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Oxidative stress and apoptosis in heart dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Nitrosative stress and pharmacological modulation of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Selective activation of the sodium-independent, cyclosporin A-sensitive calcium pore of cardiac mitochondria by doxorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Selective inhibition of muscle gene expression by oxidative stress in cardiac cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Transcriptional analysis of doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration 1Supported in part by NIH Grant HL58016. The manuscript was not subjected to internal Agency review and, thus, the opinions are those of the

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

The anthracycline antibiotics: antitumor drugs that alter chromatin structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Alterations in the myocardial creatine kinase system precede the development of contractile dysfunction in beta(1)-adrenergic receptor transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Adriamycin: Energy metabolism and mitochondrial oxidations in the heart of treated rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Effects of chronic administration of doxorubicin on myocardial creatine phosphokinase and antioxidant defenses and levels of lipid peroxidation in tissues and plasma of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Mitochondrial creatine kinase interaction with phospholipid vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009

Absence of acute doxorubicin-induced dysfunction of heart mitochondrial oxidative phosphorylation and creatine kinase activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.06.009